What is the step‑by‑step management of hyponatremia, including assessment of acute versus chronic onset, severity (mild, moderate, severe), symptomatology, and treatment options such as fluid restriction, discontinuation of offending medications, vasopressin V2‑receptor antagonists (V2 antagonists), demeclocycline, hypertonic saline, and limits on correction speed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hyponatremia Management: Step-by-Step Approach

Initial Assessment and Classification

Begin by confirming true hypotonic hyponatremia with serum osmolality <275 mOsm/kg and exclude pseudohyponatremia from hyperglycemia by adding 1.6 mEq/L to sodium for each 100 mg/dL glucose >100 mg/dL. 1

Determine Acuity and Severity

  • Acute hyponatremia is defined as onset <48 hours; **chronic hyponatremia** is >48 hours duration 2
  • Severity classification: mild (130-135 mEq/L), moderate (125-129 mEq/L), severe (<125 mEq/L) 3
  • Acute hyponatremia causes more severe symptoms than chronic hyponatremia at the same sodium level 4

Assess Volume Status

  • Hypovolemic signs: orthostatic hypotension, dry mucous membranes, decreased skin turgor, flat neck veins 2
  • Euvolemic signs: normal volume status, no edema, no orthostatic changes 2
  • Hypervolemic signs: peripheral edema, ascites, jugular venous distention, pulmonary congestion 2

Essential Laboratory Workup

  • Serum and urine osmolality, urine sodium, urine electrolytes 2
  • Serum creatinine, thyroid function (TSH), cortisol to exclude endocrine causes 1
  • Serum uric acid <4 mg/dL has 73-100% positive predictive value for SIADH 2

Treatment Based on Symptom Severity

Severe Symptomatic Hyponatremia (Medical Emergency)

For patients with confusion, delirium, altered consciousness, seizures, or coma, immediately administer 3% hypertonic saline with a target correction of 6 mmol/L over 6 hours or until severe symptoms resolve. 1

  • Give 100 mL boluses of 3% saline over 10 minutes, repeatable up to three times at 10-minute intervals 1
  • Total correction must never exceed 8 mmol/L in any 24-hour period to prevent osmotic demyelination syndrome 2, 1
  • Monitor serum sodium every 2 hours during initial correction 2, 1
  • Consider ICU admission for close monitoring 2

Moderate Symptomatic Hyponatremia

  • Symptoms include nausea, vomiting, headache, weakness, gait instability 4
  • Slower correction is appropriate: 4-8 mmol/L per day, not exceeding 8 mmol/L in 24 hours 2
  • Monitor serum sodium every 4 hours after symptom resolution 1

Asymptomatic or Mild Hyponatremia

  • Treatment focuses on addressing underlying cause and volume status 1
  • Correction rate: 4-6 mmol/L per day for chronic cases 2

Treatment Based on Volume Status

Hypovolemic Hyponatremia

Discontinue diuretics immediately and administer isotonic (0.9%) saline for volume repletion. 1

  • Initial infusion rate: 15-20 mL/kg/h, then 4-14 mL/kg/h based on response 2
  • Urine sodium <30 mmol/L predicts good response to saline (71-100% positive predictive value) 2
  • Continue until euvolemia achieved, then reassess 2

Euvolemic Hyponatremia (SIADH)

Fluid restriction to 1 L/day is the cornerstone of treatment for SIADH. 2, 1

  • If no response to fluid restriction, add oral sodium chloride 100 mEq three times daily 2
  • For severe symptoms: 3% hypertonic saline with goal of 6 mmol/L correction over 6 hours 2
  • Alternative pharmacological options for resistant cases:
    • Vasopressin V2-receptor antagonists (tolvaptan): start 15 mg once daily, titrate to 30-60 mg 2
    • Demeclocycline 2
    • Urea 2, 5
    • Loop diuretics 2

Hypervolemic Hyponatremia (Heart Failure, Cirrhosis)

Implement fluid restriction to 1-1.5 L/day for serum sodium <125 mmol/L and treat the underlying condition. 1

  • Discontinue diuretics temporarily if sodium <125 mmol/L 2
  • For cirrhotic patients: consider albumin infusion (8 g per liter of ascites removed) alongside fluid restriction 2
  • Avoid hypertonic saline unless life-threatening symptoms present, as it worsens ascites and edema 2
  • Vasopressin receptor antagonists may be considered for persistent severe hyponatremia despite fluid restriction 1

Critical Correction Rate Guidelines

Standard-Risk Patients

  • Maximum correction: 8 mmol/L in any 24-hour period 2, 1
  • Target rate: 4-8 mmol/L per day, not exceeding 10-12 mmol/L in 24 hours 2

High-Risk Patients (Requires Slower Correction)

Patients with advanced liver disease, chronic alcoholism, malnutrition, or prior encephalopathy require correction of only 4-6 mmol/L per day, with an absolute maximum of 8 mmol/L in 24 hours. 2, 1

  • These patients have 0.5-1.5% risk of osmotic demyelination syndrome even with careful correction 2
  • Cirrhotic patients with sodium ≤130 mEq/L have increased risk of spontaneous bacterial peritonitis (OR 3.40), hepatorenal syndrome (OR 3.45), and hepatic encephalopathy (OR 2.36) 2

Management of Overcorrection

If sodium correction exceeds 8 mmol/L in 24 hours, immediately discontinue current fluids and switch to D5W (5% dextrose in water). 1

  • Consider administering desmopressin to slow or reverse the rapid rise 2, 1
  • Goal: bring total 24-hour correction back to ≤8 mmol/L from baseline 2
  • Watch for signs of osmotic demyelination syndrome (dysarthria, dysphagia, oculomotor dysfunction, quadriparesis) typically occurring 2-7 days after rapid correction 2

Special Considerations: Neurosurgical Patients

Distinguishing SIADH from Cerebral Salt Wasting (CSW)

  • SIADH: euvolemic, treat with fluid restriction 2
  • CSW: hypovolemic (CVP <6 cm H₂O), treat with volume and sodium replacement, never fluid restriction 2
  • CSW requires isotonic or hypertonic saline, not fluid restriction 2
  • For severe CSW: 3% hypertonic saline plus fludrocortisone 0.1-0.2 mg daily 2
  • In subarachnoid hemorrhage patients at risk of vasospasm: avoid fluid restriction and consider fludrocortisone or hydrocortisone 2

Common Pitfalls to Avoid

  • Overly rapid correction exceeding 8 mmol/L in 24 hours causes osmotic demyelination syndrome 2
  • Inadequate monitoring during active correction 2
  • Using fluid restriction in CSW worsens outcomes 2
  • Failing to recognize and treat the underlying cause 2
  • Using hypertonic saline in hypervolemic hyponatremia without life-threatening symptoms 2
  • Ignoring mild hyponatremia (130-135 mmol/L) as clinically insignificant—it increases fall risk (21% vs 5%) and mortality (60-fold increase with sodium <130 mmol/L) 2, 4

Monitoring Protocol

During Active Correction

  • Severe symptoms: check sodium every 2 hours 2, 1
  • Mild symptoms: check every 4 hours after symptom resolution 1
  • Chronic hyponatremia: daily monitoring until target achieved 1

Long-term Follow-up

  • Continue monitoring to ensure underlying cause is addressed 2
  • Reassess volume status and adjust treatment accordingly 1
  • Watch for recurrence, especially in patients with chronic conditions like cirrhosis or heart failure 2

References

Guideline

Hyponatremia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Sodium Imbalance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hyponatremia Symptoms and Complications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.